2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

被引：848

作者：

Mach, Francois ^{[1
]}

Baigent, Colin ^{[2
]}

Catapano, Alberico L. ^{[3
]}

Koskina, Konstantinos C. ^{[4
]}

Casula, Manuela ^{[5
,6
]}

Badimon, Lina ^{[7
,8
]}

Chapman, M. John ^{[9
,10
,29
]}

De Backer, Guy G. ^{[11
]}

Delgado, Victoria ^{[12
]}

Ference, Brian A. ^{[13
]}

Graham, Ian M. ^{[14
]}

Halliday, Alison ^{[15
]}

Landmesser, Ulf ^{[16
,17
,18
]}

Mihaylova, Borislava ^{[19
,20
]}

Pedersen, Terje R. ^{[6
,21
]}

Riccardi, Gabriele ^{[22
]}

Richter, Dimitrios J. ^{[23
]}

Sabatine, Marc S. ^{[24
,25
]}

Taskinen, Marja-Riitta ^{[26
]}

Tokgozoglu, Lale ^{[27
]}

Wiklund, Olov ^{[28
]}

Windecker, Stephan

Aboyans, Victor

Baigent, Colin ^{[2
]}

Collet, Jean-Philippe

Dean, Veronica

Delgado, Victoria ^{[12
]}

Fitzsimons, Donna ^{[1
]}

Gale, Chris P.

Grobbee, Diederick

Halvorsen, Sigrun

Hindricks, Gerhard

Iung, Bernard

Juni, Peter

Katus, Hugo A.

Leclercq, Christophe

Lettino, Maddalena

Lewis, Basil S.

Merkely, Bela

Mueller, Christian

Petersen, Steffen

Petronio, Anna Sonia

Roffi, Marco

Shlyakhto, Evgeny

Simpson, Iain A.

Sousa-Uva, Miguel

Touyz, Rhian M.

Nibouche, Djamaleddine ^{[30
]}

Zelveian, Parounak H. ^{[31
]}

Siostrzonek, Peter ^{[32
]}

机构：

[1] Geneva Univ Hosp, Dept Cardiol, 4 Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland

[2] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England

[3] Univ Milan, Dept Pharmacol & Biomol Sci, Multimed IRCCS, Via Balzaretti 9, I-20133 Milan, Italy

[4] Bern Univ Hosp, Inselspital, Cardiol, Bern, Switzerland

[5] Univ Milan, Epidemiol & Prevent Pharmacol Serv SEFAP, Dept Pharmacol & Biomol Sci DiSFeB, Milan, Italy

[6] IRCCS MultiMed, Milan, Italy

[7] IR Hosp Santa Creu & St Pau, Cardiovasc Program ICCC, Barcelona, Spain

[8] IR Hosp Santa Creu & St Pau, CiberCV, Barcelona, Spain

[9] INSERM, Natl Inst Hlth & Med Res, Paris, France

[10] Pitie Salpetriere Univ Hosp, Div Endocrinol Metab, Paris, France

[11] Univ Ghent, Publ Hlth & Primary Care, Fac Med & Hlth Sci, Ghent, Belgium

[12] Leiden Univ, Med Ctr, Cardiol, Leiden, Netherlands

[13] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Naturally Randomized Trials, Cambridge, England

[14] Trinity Coll Dublin, Cardiol, Dublin, Ireland

[15] Univ Oxford, Nuffield Dept Surg, NIHR Oxford Biomed Res Ctr, Oxford, England

[16] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany

[17] Berlin Inst Hlth, Berlin, Germany

[18] German Ctr Cardiovasc Res DZHK, Berlin, Germany

[19] Univ Oxford, NIHR Oxford Biomed Res Ctr, Nuffield Dept Populat Hlth, Oxford, England

[20] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England

[21] Oslo Univ Hosp, Prevent Cardiol, Oslo, Norway

[22] Univ Naples Federico II, Clin Med & Surg, Naples, Italy

[23] Euroclin, Dept Cardiac, Athens, Greece

[24] Womens Hosp Med Ctr, Div Cardiovasc Med, TIMI Study Grp, Boston, MA USA

[25] Harvard Med Sch, Boston, MA 02115 USA

[26] Univ Helsinki, Res Program Clin & Mol Metab, Helsinki, Finland

[27] Hacettepe Univ, Cardiol, Ankara, Turkey

[28] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden

[29] Sorbonne Univ, Paris, France

[30] Algerian Soc Cardiol, Algiers, Algeria

[31] Armenian Cardiologists Assoc, Yerevan, Armenia

[32] Austrian Soc Cardiol, Vienna, Austria

[33] Azerbaijan Soc Cardiol, Baku, Azerbaijan

[34] Belgian Soc Cardiol, Ixelles, Belgium

[35] Assoc Cardiologists Bosnia & Herzegovina, Sarajevo, Bosnia & Herceg

[36] Bulgarian Soc Cardiol, Sofia, Bulgaria

[37] Cyprus Soc Cardiol, Strov Nicosia, Cyprus

[38] Czech Soc Cardiol, Brno, Czech Republic

[39] Danish Soc Cardiol, Copenhagen, Denmark

[40] Egyptian Soc Cardiol, Giza, Egypt

[41] Estonian Soc Cardiol, Tallinn, Estonia

[42] Finnish Cardiac Soc, Oulu, Finland

[43] French Soc Cardiol, Paris, France

[44] Georgian Soc Cardiol, Tbilisi, Georgia

[45] German Cardiac Soc, Dusseldorf, Germany

[46] Hellen Soc Cardiol, Athens, Greece

[47] Hungarian Soc Cardiol, Budapest, Hungary

[48] Iceland Soc Cardiol, Reykjavik, Iceland

[49] Irish Cardiac Soc, Dublin, Ireland

[50] Israel Heart Soc, Ramat Gan, Israel

来源：

ATHEROSCLEROSIS | 2019年 / 290卷

关键词：

Guidelines; Dyslipidaemias; Cholesterol; Triglycerides; Low-density lipoproteins; High-density lipoproteins; Apolipoprotein B; Lipoprotein(a); Lipoprotein remnants; Total cardiovascular risk; Treatment (lifestyle); Treatment (drugs); Treatment (adherence); Very low-density lipoproteins; Familial hypercholesterolaemia; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; HIGH-DOSE ATORVASTATIN; TYPE-2; DIABETES-MELLITUS; ALL-CAUSE MORTALITY; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; STATIN-TREATED PATIENTS; INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE;

D O I：

10.1016/j.atherosclerosis.2019.08.014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：140 / 205

页数：66

共 604 条

[1] Severe congenital autoimmune neutropenia in preterm monozygotic twins: case series and literature review [J].

Abdelhamid, Rehab ;

Yusuf, Kamran ;

Lodha, Abhay ;

Al Awad, Essa Hamadan .

CASE REPORTS IN PERINATAL MEDICINE, 2018, 7 (02)

[2] Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].

Abifadel, M ;

Varret, M ;

Rabès, JP ;

Allard, D ;

Ouguerram, K ;

Devillers, M ;

Cruaud, C ;

Benjannet, S ;

Wickham, L ;

Erlich, D ;

Derré, A ;

Villéger, L ;

Farnier, M ;

Beucler, I ;

Bruckert, E ;

Chambaz, J ;

Chanu, B ;

Lecerf, JM ;

Luc, G ;

Moulin, P ;

Weissenbach, J ;

Prat, A ;

Krempf, M ;

Junien, C ;

Seidah, NG ;

Boileau, C .

NATURE GENETICS, 2003, 34 (02) :154-156

[3]

Agarwal Arnav, 2016, World J Transplant, V6, P125, DOI 10.5500/wjt.v6.i1.125

[4] Effects of statins on renal function [J].

Agarwal, R .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (05) :748-755

[5] The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management Recommendations [J].

Agarwala, Anandita ;

Jones, Peter ;

Nambi, Vijay .

CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (01) :1-8

[6]

AGMON J, 1992, CIRCULATION, V86, P839

[7] Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial [J].

Ahern, Amy L. ;

Wheeler, Graham M. ;

Aveyard, Paul ;

Boyland, Emma J. ;

Halford, Jason C. G. ;

Mander, Adrian P. ;

Woolston, Jennifer ;

Thomson, Ann M. ;

Tsiountsioura, Melina ;

Cole, Darren ;

Mead, Bethan R. ;

Irvine, Lisa ;

Turner, David ;

Suhrcke, Marc ;

Pimpin, Laura ;

Retat, Lise ;

Jaccard, Abbygail ;

Webber, Laura ;

Cohn, Simon R. ;

Jebb, Susan A. .

LANCET, 2017, 389 (10085) :2214-2225

[8] Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis [J].

Akioyamen, Leo E. ;

Genest, Jacques ;

Shan, Shubham D. ;

Reel, Rachel L. ;

Albaum, Jordan M. ;

Chu, Anna ;

Tu, Jack V. .

BMJ OPEN, 2017, 7 (09)

[9] No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials [J].

Al-Gobari, Muaamar ;

Le, Hai-Ha ;

Fall, Mor ;

Gueyffier, Francois ;

Burnand, Bernard .

PLOS ONE, 2017, 12 (02)

[10] Safety and Effectiveness of Ezetimibe in Liver Transplant Recipients with Hypercholesterolemia [J].

Almutairi, Fawaz ;

Peterson, Theresa C. ;

Molinari, Michele ;

Walsh, Mark J. ;

Alwayn, Ian ;

Peltekian, Kevork M. .

LIVER TRANSPLANTATION, 2009, 15 (05) :504-508

← 1 2 3 4 5 6 7 8 9 10 →